LINDSAY BIAS: Open Payments
NPI 1649794959 · HUNTINGTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$806 in 30 payments from 8 companies in 2025. Trend: 2023 $698 · 2024 $1,157 · 2025 $806
Food & beverage: $780Education: $26
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $200 |
| PFIZER INC. | 4 | $178 |
| GlaxoSmithKline, LLC. | 6 | $154 |
| AstraZeneca Pharmaceuticals LP | 6 | $108 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Caris MPI, Inc. | 1 | $34 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $33 |
| Verastem, Inc. | 1 | $23 |
Products named: ELAHERE, TIVDAK, ZEJULA, LYNPARZA, IMFINZI, MI CANCER SEEK, JOURNAVX, KEYTRUDA.
Industry payments across WV — which companies pay providers there.
